Not applicableUnknownNCT05483725
What this trial is testing
Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.
Who this might be right for
Kidney DiseasesKidney Transplant; ComplicationsCOVID-19+3 more
Institute for Clinical and Experimental Medicine 108